STAT3 is Overactivated in Gastric Cancer Stem-Like Cells

(Pages: 617-628)
Monireh Hajimoradi, M.Sc, 1Zuhair Mohammad Hassan, Ph.D, 1,*Marzieh Ebrahimi, Ph.D, 2,*Masoud Soleimani, Ph.D, 3Mahdieh Bakhshi, M.D, 4Javad Firouzi, B.Sc, 2Fazel Sahraneshin Samani, M.Sc, 2
Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
Department of Stem Cells and Developmental Biology, Cell Sciences Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
Department of Molecular Medicine, Faculty of Advanced Medical Technologies, Gorgan University of Medical Sciences, Gorgan, Iran
Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
Department of Stem Cells and Developmental Biology, Cell Sciences Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
Department of Molecular Medicine, Faculty of Advanced Medical Technologies, Gorgan University of Medical Sciences, Gorgan, Iran
* Corresponding Addresses: P.O.Box: 14117-13116 Department of Immunology Faculty of Medical Sciences Tarbiat Modares University TehranIran P.O.Box: 16635-148 Department of Stem Cells and Developmental Biology Cell Sciences Research Center Royan Institute for Stem Cell Biology and Technology ACECR TehranIran Emails: hasan_zm@modares.ac.ir, mebrahimi@royaninstitute.org
Any use, distribution, reproduction or abstract of this publication in any medium, with the exception of commercial purposes, is permitted provided the original work is properly cited This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Hajimoradi Monireh, Mohammad Hassan Zuhair, Ebrahimi Marzieh, Soleimani Masoud, Bakhshi Mahdieh, Firouzi Javad, Samani Fazel Sahraneshin. STAT3 is Overactivated in Gastric Cancer Stem-Like Cells . Cell J. 2016; 17(4): 617-628.

Abstract

Objective

Gastric cancer (GC) is widely associated with chronic inflammation. The pro inflammatory microenvironment provides conditions that disrupt stem/progenitor cell proliferation and differentiation. The signal transducer and activator of transcrip- tion-3 (STAT3) signaling pathway is involved in inflammation and also contributes to the maintenance of embryonic stem cell (ESCs) pluripotency. Here, we have investi- gated the activation status of STAT3 in GC stem-like cells (GCSLCs).

Materials and Methods

In this experimental research, CSLCs derived from the human GC cell line MKN-45 and patient specimens, through spheroid body formation, character- ized and then assayed for the STAT3 transcription factor expression in mRNA and protein level further to its activation.

Results

Spheroid cells showed higher potential for spheroid formation than the pa- rental cells. Furthemore, stemness genes NANOG, c-MYC and SOX-2 were over expressed in spheroids of MKN-45 and in patient samples. In MKN-45 spheroid cells, epithelial mesenchymal transition (EMT) related markers CDH2, SNAIL2, TWIST and VIMENTIN were upregulated (P<0.05), but we observed no change in expression of the E-cadherin epithelial marker. These cells exhibited more resistance to docetaxel (DTX) when compared with parental cells (P<0.05) according to the MTS assay. Al- though immunostaining and Western blotting showed expression of the STAT3 pro- tein in both spheroids and parents, the mRNA level of STAT3 in spheroids was higher than the parents. Nuclear translocation of STAT3 was accompanied by more intensive phospho-STAT3 (p-STAT3) in spheroid structures relative to the parent cells accord- ing to flow cytometry analysis (P<0.05).

Conclusion

The present findings point to STAT3 over activation in GCSLCs. Com- plementary experiments are required to extend the role of STAT3 in stemness fea- tures and invasion properties of GCSCs and to consider the STAT3 pathway for CSC targeted therapy.